FQTEX
Price
$11.81
Change
+$0.12 (+1.03%)
Updated
Apr 17 closing price
Net Assets
305.2M
RIEBX
Price
$24.61
Change
+$0.15 (+0.61%)
Updated
Apr 17 closing price
Net Assets
123.85B
Ad is loading...

FQTEX vs RIEBX

Header iconFQTEX vs RIEBX Comparison
Open Charts FQTEX vs RIEBXBanner chart's image
Franklin Templeton SMACS: Series E Adv
Price$11.81
Change+$0.12 (+1.03%)
VolumeN/A
Net Assets305.2M
American Funds Income Fund of Amer R2E
Price$24.61
Change+$0.15 (+0.61%)
VolumeN/A
Net Assets123.85B
FQTEX vs RIEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FQTEX vs. RIEBX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FQTEX is a StrongBuy and RIEBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIEBX has more cash in the bank: 124B vs. FQTEX (305M). FQTEX pays higher dividends than RIEBX: FQTEX (6.06) vs RIEBX (3.39). FQTEX was incepted earlier than RIEBX: FQTEX (6 years) vs RIEBX (11 years). RIEBX (1.07) is less costly to investors than FQTEX (0.11). FQTEX (93.40) and RIEBX (92.00) have comparable annual turnover. FQTEX has a lower initial minimum investment than RIEBX: FQTEX (0) vs RIEBX (250). RIEBX annual gain was more profitable for investors over the last year : 9.44 vs. FQTEX (4.40). FQTEX return over 5 years is better than : 61.50 vs. RIEBX (33.99).
FQTEXRIEBXFQTEX / RIEBX
Total Expense Ratio0.001.07-
Annual Report Gross Expense Ratio0.111.0710%
Fund Existence6 years11 years-
Gain YTD-4.4151.663-266%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets305M124B0%
Annual Yield % from dividends6.063.39179%
Returns for 1 year4.409.4447%
Returns for 3 years10.645.60190%
Returns for 5 years61.5033.99181%
Returns for 10 yearsN/A28.72-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMYZX37.810.06
+0.16%
Putnam Core Equity Fund R
LMNOX34.87N/A
N/A
Patient Opportunity I
CMJIX37.19N/A
N/A
Calvert US Mid Cap Core Rspnb Idx I
VKSEX9.26N/A
N/A
Virtus KAR Small-Mid Cap Value C
AIBBX13.25N/A
N/A
Aristotle Small Cap Equity I-2